Pharmaceutical

Biocytogen and Myricx Bio partner for development of ADCs

Biocytogen and Myricx Bio have signed an antibody evaluation, option and licence agreement for the development of ADCs.

Sep 9, 2023 - 20:00
Biocytogen and Myricx Bio partner for development of ADCs
Biocytogen and Myricx Bio have signed an antibody evaluation, option and licence agreement for the development of ADCs.
Read the original article

Tags:

Previous Article

EC expands indication approval for Merck’s Ebola vaccine

Next Article

Subcutaneous drugs grant a new lease on life to checkpoint inhibitors

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Michael J. Fox on how far Parkinson’s research has come: ‘We don’t want to be celebrated. We want to get things done’

Michael J. Fox on how far Parkinson’s research has come...

Oct 20, 2023

STAT+: Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

STAT+: Acadia’s Nuplazid fails as treatment for schizop...

Mar 12, 2024

Opinion: There’s a public health crisis lurking in our data: the Census option ‘some other race’

Opinion: There’s a public health crisis lurking in our ...

Dec 19, 2023